![Young-Chul Sung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Young-Chul Sung
Founder at GENEXINE, INC.
Net worth: 31 M $ as of 31/05/2024
Network origin in Young-Chul Sung first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 22 | |
Pohang University of Science & Technology
18
| College/University | Other Consumer Services | 18 |
Public Company | Pharmaceuticals: Major | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Young-Chul Sung via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Seoul National University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Yonsei University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
HANDOK INC. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Korea Advanced Institute of Science & Technology | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
NOVMETAPHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chief Operating Officer Director of Finance/CFO | |
pH Pharma Co., Ltd.
![]() pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
PT Kalbe Genexine Biologics
![]() PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Biotechnology | Chief Operating Officer Director/Board Member | |
Weill Cornell Medical College | College/University | Doctorate Degree Doctorate Degree | |
University of Massachusetts | College/University | Doctorate Degree Doctorate Degree | |
University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree | |
CYTODYN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
I-Mab Bio-tech (Tianjin) Co. Ltd.
![]() I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Biotechnology | Director/Board Member Director/Board Member | |
JEIL TECHNOS CO.,LTD | Forest Products | Comptroller/Controller/Auditor Director/Board Member | |
NEOIMMUNETECH, INC. | Biotechnology | Founder Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Doctorate Degree | |
Burrill LLC
![]() Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
SK Holdings, Inc.
![]() SK Holdings, Inc. BroadcastingConsumer Services Part of Match Group, Inc., SK Holdings, Inc. is a company based in New York, NY. | Broadcasting | Corporate Officer/Principal | |
Asia Wind Energy Association | Chairman | ||
UNISON CO., LTD. | Electrical Products | Director/Board Member | |
Portola Capital Partners
![]() Portola Capital Partners Investment ManagersFinance Portola Capital Partners is a private equity firm founded in 1992. The firm is headquartered in Silicon Valley, California. | Investment Managers | Private Equity Investor | |
INFINERA CORPORATION | Telecommunications Equipment | Founder | |
Korea Evaluation Institute of Industrial Technology
![]() Korea Evaluation Institute of Industrial Technology Miscellaneous Commercial ServicesCommercial Services Korea Evaluation Institute of Industrial Technology operates as a research institute to develop technology for domestic industries. The company is based in Daegu, South Korea. The South Korean company is ultimately controlled by the Government of South Korea. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AffaMed Therapeutics
![]() AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | Pharmaceuticals: Major | Chairman | |
EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Director/Board Member | |
InxMed Biotechnology Nanjing Co., Ltd.
![]() InxMed Biotechnology Nanjing Co., Ltd. BiotechnologyHealth Technology InxMed Biotechnology Nanjing Co., Ltd. is a clinical-stage biotech company established in 2018, dedicated to developing innovative therapies to overcome treatment resistance, especially anti PD-1/PD-L1 resistance. InxMed is based in Nanjing, China, and has teams located in Shanghai and Beijing, with hubs in San Francisco and Melbourne. The Chinese company's innovations are inspired by patients and driven by in-depth understanding of disease biology and pharmacology. InxMed has raised tens of millions of US dollars in series A round financing and has an integrated high-caliber research and clinical development team across China, the US, and Australia. The company has built a unique innovative pipeline through its own discovery research and development and collaborative research and development. The company was founded in 2018 by Fei Cao and Zai Qi Wang, with Zai Qi Wang serving as the CEO since then. | Biotechnology | Director/Board Member | |
C-Bridge Capital Partners LLC | Corporate Officer/Principal | ||
CBC Group (Singapore) Pte. Ltd.
![]() CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Investment Managers | Private Equity Investor | |
C-Bridge Capital LLC
![]() C-Bridge Capital LLC Investment ManagersFinance C-Bridge Capital LLC (C-Bridge Capital) is a venture capital subsidiary of CBC Group founded in 2019 by Fu Wei. The firm is headquartered in New York.. | Investment Managers | Private Equity Investor | |
I-MAB Biopharma Co., Ltd.
![]() I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
HUGEL, INC. | Biotechnology | Director/Board Member | |
Michigan State University | College/University | Doctorate Degree | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
Daegu National science Museum | Director/Board Member | ||
Sanofi-Aventis Groupe SA
![]() Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Financial Conglomerates | Corporate Officer/Principal | |
JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Graduate Degree | |
Luca Science, Inc.
![]() Luca Science, Inc. BiotechnologyHealth Technology Luca Science, Inc. is a Japanese preclinical stage biopharmaceutical company that specializes in mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tissues and organs. Luca Science is based in Chuo-ku, JP, and was founded in December 2018 by Masashi Suganuma. The company uses its platform technology to manufacture, store, and deliver innovative mitochondrial drugs to research and develop therapeutics for unmet medical needs in a wide range of diseases for which there have been no effective treatments. The CEO is Rick C. Tsai. | Biotechnology | Director/Board Member | |
KISWIRE LTD. | Metal Fabrication | Director/Board Member | |
ATINUM INVESTMENT CO., LTD | Investment Managers | Director/Board Member | |
Purdue University | College/University | Doctorate Degree | |
LG CHEM, LTD. | Chemicals: Specialty | Director/Board Member | |
LX HAUSYS, LTD. | Chemicals: Specialty | Director/Board Member | |
POSCO FUTURE M CO., LTD. | Chemicals: Specialty | Director/Board Member | |
HANWHA SOLUTIONS CORPORATION | Semiconductors | Director/Board Member |
Statistics
International
South Korea | 21 |
United States | 20 |
China | 6 |
France | 3 |
Japan | 3 |
Sectoral
Health Technology | 18 |
Consumer Services | 14 |
Finance | 7 |
Electronic Technology | 4 |
Process Industries | 4 |
Operational
Director/Board Member | 119 |
Corporate Officer/Principal | 62 |
Independent Dir/Board Member | 42 |
Doctorate Degree | 34 |
Chief Executive Officer | 29 |
Most connected contacts
Insiders | |
---|---|
Ho Young Huh | 32 |
In-Joon Song | 18 |
Michael Keyoung | 17 |
Young-Jin Kim | 15 |
Neil Warma | 15 |
Gil Labrucherie | 15 |
David Welch | 14 |
Samir R. Patel | 9 |
Mi-Jung Ahn | 9 |
Philippe Fauchet | 9 |
Seline E. Miller | 6 |
In-Sang Jeong | 6 |
Hyuk-Jong Lee | 5 |
Se-Hwan Yang | 5 |
Junghee Lim | 5 |
- Stock Market
- Insiders
- Young-Chul Sung
- Company connections